Drugs / XL784
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00312780 | Mar 2006 → Oct 2007 | diabetic kidney disease, proteinuria | Symphony Evolution, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XL784 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00312780 ↗ |
| Action | Inhibit | “metalloproteinase inhibitor, inhibiting both ADAMs” NCT00312780 ↗ |
| Modality | Small molecule | “XL784 is a small molecule reno-protective metalloproteinase inhibitor” NCT00312780 ↗ |
| Route | Oral | “orally administered” NCT00312780 ↗ |